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EPLY
he specific commission of our review, titled “The Year in
therothrombosis,” was to highlight clinically relevant studies in
he field published within the last year (1). The letter from Dr.
omı´nguez-Rodriguez and colleagues highlights the importance
f the circadian rhythm in the presentation of acute coronary
vents, a concept established several years ago. The last citation of
heir letter quotes a study published in 2004, evaluating the
ight/dark cycle of cytokines and melatonin plasma levels in
atients with acute myocardial infarction (AMI) (2). This single,
bservational, case-control study suggested an association between
igh levels of interleukin-6 and low levels of melatonin during the
ark cycle in patients with AMI. The investigators should be
ongratulated for their effort. However, the study is not mecha-
istic, and does not prove causality. Furthermore, the clinical
ignificance of their findings still remains to be elucidated. As a
esult, in our judgment the study may not meet the criteria to be
ncluded as a clinically relevant publication in atherothrombosis in
he year 2004.
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iruses and Other Environmental Factors as
ossible Sources of Phenotypic Heterogeneity
n Familial Dilated Cardiomyopathy
n their interesting and recent state-of-the-art study, Burkett and
ershberger (1) stated that “familial dilated cardiomyopathy
DCM) demonstrates incomplete penetrance, variable expression,
nd significant locus and allelic heterogeneity, making clinical and
enetic diagnosis complex.” The statement clearly describes a key
roblem encountered during the genetic dissection of human
CM. This problem reaches beyond the fact that multiple genes
ay cause the DCM phenotype in humans and that further loci
hall be revealed in the future. Even within a single DCM family
r within a group of unrelated DCM patients harboring defects in
he same gene, there is often very large and currently unexplained
henotypic heterogeneity. There are at least two possible sources
or this heterogeneity.
First, unless representative healthy control populations are
creened for a given mutation one cannot be sure that this
utation is capable of causing the phenotype without additional
ofactors (modifier genes or environmental agents) being present.
n other genetic disorders the screening of large control popula-
ions has been the indispensable basis for the discovery of such
ofactors. For example, smoking was identified as an essential
nvironmental factor for the development of lung disease in
enetic 1-antitrypsin deficiency, initially assumed to cause the
isease per se on a pure genetic basis. For most mutations
ssociated with DCM we do not yet have frequency data repre-
entative of the general healthy population that can be compared
ith the rather small DCM patient cohorts from which the disease
ssociation is usually derived. The relative pathogenic contribution
f the gene defect per se as compared to hitherto unknown
ofactors is therefore uncertain.
Second, data on possible environmental agents are sparse in
olecular genetic studies of familial DCM. Regarding such
ofactors, we have recently detected cardiac viral infections in 165
67.4%) of 245 cases in a molecular virological survey based on
yocardial biopsies from a series of DCM patients (2), with a
road spectrum of virus species being involved. Cardiotropic
iruses thus emerged as prevalent environmental factors that may
ossibly cause or influence the course of DCM. The high fre-
uency of cardiotropic viruses detected in that DCM series makes
t highly likely that cardiac viruses are also encountered in familial
CM. They may explain part of the large phenotypic heteroge-
eity mentioned by Burkett and Hershberger (1), but will go
nnoticed unless cardiac biopsies are specifically investigated using
olecular virological methods. A synopsis of the current data
uggests that a comprehensive picture of the pathogenesis of
amilial DCM can only be obtained if both genetic and environ-
ental factors are analyzed. Studies of this type may lead to the
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February 7, 2006:683–91dentification of important new genome-environment interactions
n DCM pathogenesis (3) and also have implications for the
linical management of DCM patients.
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EPLY
e appreciate the interest in our recent review (1) of the genetic
asis of dilated cardiomyopathy from Drs. Poller, Schultheiss, and
ühl. We agree with the first point that the screening of healthy,
nselected populations is always important to more fully under-
tand genetic variation. We also agree with the general premise of
he second point that understanding gene/environment interac-
ions can be helpful, and at times essential, for understanding the
athogenesis and progression of genetic disease.
We also suggest that the first point of Drs Poller and colleagues
“ . . . unless representative healthy populations are screened . . . ”)
ay be even more important for their work (2) to ascertain any role
f viruses in causing idiopathic dilated cardiomyopathy (IDC). In
heir study only myocardial samples from patients with IDC were
xamined for virus, but no myocardial samples from any control
roup (e.g., ischemic cardiomyopathy, or a “representative healthy
opulation”) were reported. This raises the question of whether
iruses, ubiquitous in all living organisms and perhaps equally so in
ontrol myocardium, are relevant for IDC.
Although it is likely that environmental influences affect pen-
trance and phenotype, it is also clear that a great deal of
henotypic variation can be attributed to epigenetic variation
ndependent of environmental influence. Transcriptionally compe-
ent retrotransposons likely number in the thousands in mamma-
ian genomes, and, for example, have been shown to cause the
onsiderable phenotypic variation that is routinely observed in
sogenic mice strains (3). Understanding the genetic, epigenetic,
nd environmental factors that cause or modify human disease will
equire a great deal of careful effort supported by the most robust
ontrols possible. iRay E. Hershberger, MD
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regon Health and Science University
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ardiovascular Manifestations
f Carbon Monoxide Poisoning
e read with interest the report by Satran et al. (1) on the
ardiovascular manifestations of carbon monoxide (CO) poison-
ng. In the Hospital Rı´o Hortega of Valladolid (Spain), we
ollowed CO poisonings prospectively for two years (2). The
rotocol included, among other parameters, carboxyhemoglobin
COHb) levels, electrocardiogram (ECG), creatine kinase (CK)
nd CK-MB. During the study period studied, 154 patients were
ncluded, of whom 20% (n 31) presented sinusal tachycardia, 5%
n  8) arrhythmias (mainly auricular fibrillation), and 4% (n  6)
schemic changes, including one patient in whom cardiac cathe-
erization was carried out without findings of coronary artery
isease. Eight (7.2%) adult patients and 25.6% (n 10) of patients
nder 10 years of age had elevated CK levels. Similarly, CK-MB
evels were elevated in 1.8% (n  2) of adults and in 12.7% (n 
) of children (p  0.01) (2). In our series, the percentage of
atients with cardiovascular manifestations is inferior to that
escribed by Satran et al. (1). We suggest that this is because our
tudy population included all CO poisonings, of which 40% were
ild (COHb 25%), whereas Satran et al. (1) included only
oderate or severe poisonings. The fact that elevated CK and
K-MB levels occur more frequently in children than in adults
uggests a greater toxicity or affinity of CO for the pediatric
usculature, although this hypothesis remains to be verified.
Satran et al. (1) report that, in an unspecified number of
atients, the etiology of the CO poisoning was fire exposure, and
hat eight patients died owing to burn injuries (1), but they make
o reference to plasma lactate concentrations. Lactate is the
rincipal marker of cyanide (CN) in the blood of patients who
nhale fire smoke, and levels greater than 10 mmol/l suggest that,
n these patients, CN plays a more important role than does CO
3,4). We suggest that a percentage of the myocardial ischemias
escribed by Satran et al. (1) may be due to fire smoke inhalation
yndrome and not solely to CO poisoning. Smoke from fires
ontains a mixture of gases, but of these it is CO and CN that
rovoke tissue hypoxia and may lead to death (5). Although the
rotagonism of CO in the multifactorial hypoxia of fire smoke
nhalation syndrome is well known, the role of CN is less so (4).
